The Infections and Cancer units primarily study infection-attributable cancers and their related pathogens.
The Infections and Cancer Laboratory (INCALAB) develops and implements new molecular tools to improve prevention and treatment of oncological diseases associated with viral infections, particularly to human papillomavirus (HPV).
INCALAB conducts basic research to generate new knowledge on the natural history and progression of HPV infection, as well as pre-clinical studies to identify new molecular markers to increase the accuracy of current routine screening and diagnostic tools. INCALAB also collaborates with in vitro diagnostic (IVD) companies to evaluate the sensitivity and specificity of newly marketed diagnostic tests.
Furthermore, INCALAB provides technical and molecular support to research projects led by UNIC EMG and UNIC II. It also supports the cervical cancer screening programme in Catalonia as a reference lab for assessing the inter-laboratory reproducibility of HPV testing.